ODESSA, FL--(Marketwired - Jul 21, 2016) - Dais Analytic Corporation (OTCQB: DLYT), a commercial nanotechnology materials business selling its industry-changing technology into the worldwide energy and water markets, announced today it has shipped its fourth order of its NanoClear™ units to a targeted customer focused on bringing on-line cost effective industrial waste water treatment systems to China. Each unit is capable of producing 2.5 tons of clean water a day.
"We are actively pursuing opportunities in the USA, China, Europe and India," says John Herrin, Chief Operating Officer at Dais. "NanoClear™ has many benefits over existing technologies for treating industrial wastewater and presents customers with a compelling value. It is exciting to see the level of interest we're finding among engineers, water treatment specialists, environmentalists, and others in the waste water clean-up industry."
The NanoClear product line is a key application in purifying contaminated water having high salt content, low pH, or where the need for Total Dissolved Solid in the product water is 10 or less.
Despite the success of the NanoClear product line, on July 19, 2016 the public trading of Dais stock experienced a drop in the price per share due to isolated heavy selling volume. This drop has nothing to do with Dais's technology or its business prospects. The opportunity and the future growth projections continue to move according to plan.
The Company believes that a firm, acting on behalf of New York State, acquired through a bureaucratic process approximately 3.7M shares of Dais common stock held by some shareholders who did not respond to communications sent by the firm on behalf of the State of New York.
When owners of assets such as stock certificates or other assets do not actively manage their assets for one reason or another, such as the holder's death, inattention, or unplanned event, a state, the State of New York in this case, may take ownership of these unclaimed assets.
It appears that the clearing house company that acquired the 3.7M shares of Dais stock on behalf of New York State may have started selling the stock late in the trading day on July 19, selling 1.4M shares in a few minutes. Short positions were filled, and the price of the stock dropped significantly.
The entire company remains bullish on its prospects as the business opportunity remains the same -- solid and moving ahead.
"We will do what we are able to in order to address this matter as soon as possible," said John Herrin.
About Dais Analytic Corporation
Dais Analytic Corporation (OTCQB: DLYT) is a nanotechnology business producing a versatile family of membrane materials -- called Aqualyte -- focusing on evolutionary or disruptive air, energy and water applications. The uses include:
- ConsERV™, a commercially available engineered energy recovery ventilator (an HVAC product) useful for efficient management of ventilation air's temperature and moisture content using the energy found in the outgoing 'stale' air stream to pre-condition the incoming fresh air often saving energy, CO2, and allowing for equipment downsizing;
- NanoClear™, an early beta-stage method for treating contaminated water (notably most all forms of industrial waste), to provide pure drinking water;
- NanoAir™, an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle useful to replace the existing gas based compression cooling cycle in most all forms of air-conditioning and refrigeration saving a projected 50% in energy and CO2;
Each use demonstrates the diversity of Dais' core product -- Aqualyte™ -- the family of nano-structured polymers and engineered processes having a focus on minimizing consumption of irreplaceable natural resources, and ending the degradation of our environment. To find out more about Dais please visit www.daisanalytic.com, and to learn more about ConsERV™ please visit www.conserv.com.
Safe Harbor Statement
This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. For example, statements about the future sales volume are forward looking and subject to risks. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, risks outlined in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.